First vaccine to protect adults from Chikungunya

View source ↗

Summary

EMA announced Ixchiq, the first chikungunya vaccine for adults, is being assessed under the OPEN framework to promote global public health.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya

Drugs mentioned

• Ixchiq

Snippet

Ixchiq was assessed under the OPEN framework to promote global public health